Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol 2017;216(6):580 e1- e9. https://www.ncbi.nlm.nih.gov/pubmed/28188769
Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 2013;62(8):1153–9. https://www.ncbi.nlm.nih.gov/pubmed/22619368
Morch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard O. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 2017;377(23):2228–39. https://www.ncbi.nlm.nih.gov/pubmed/29211679
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117(5):1105–13. https://www.ncbi.nlm.nih.gov/pubmed/21508749
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015;(8):CD011054. https://www.ncbi.nlm.nih.gov/pubmed/26310586
Schaffir J, Worly BL, Gur TL. Combined hormonal contraception and its effects on mood: a critical review. Eur J Contracept Reprod Health Care 2016;21(5):347–55. https://www.ncbi.nlm.nih.gov/pubmed/27636867
Skovlund CW, Morch LS, Kessing LV, Lidegaard O. Association of hormonal contraception with depression. JAMA Psychiatry 2016;73(11):1154–62. https://www.ncbi.nlm.nih.gov/pubmed/27680324
Triebwasser JE, Higgins S, Secura GM, Zhao Q, Peipert JF. Pharmacy claims data versus patient self-report to measure contraceptive method continuation. Contraception 2015;92(1):26–30. https://www.ncbi.nlm.nih.gov/pubmed/25858677
